EMBLA — Embla Medical hf Balance Sheet
0.000.00%
- DKK16.22bn
- DKK19.19bn
- $854.89m
- 78
- 22
- 87
- 71
Annual balance sheet for Embla Medical hf, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 102 | 85.2 | 76.6 | 72.7 | 87.6 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 112 | 107 | 117 | 133 | 129 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 326 | 318 | 349 | 376 | 397 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 171 | 182 | 179 | 186 | 200 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,214 | 1,247 | 1,325 | 1,386 | 1,539 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 147 | 186 | 237 | 196 | 209 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 642 | 625 | 690 | 684 | 762 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 573 | 622 | 636 | 702 | 777 |
| Total Liabilities & Shareholders' Equity | 1,214 | 1,247 | 1,325 | 1,386 | 1,539 |
| Total Common Shares Outstanding |